8/9/2002 - IP Infusion introduced version 4.2 of its ZebOSTM Advanced Routing Suite (ARS). IP Infusion has expanded its advanced IP routing and switching solutions to now include MPLS Layer 2 Virtual Circuit support. The MPLS Layer 2 Virtual Circuit feature is fully integrated into the ZebOS ARS product and complements IP Infusion's current MPLS BGP-VPN capabilities. This source code software solution is also integrated with IP Infusion's OSPF, BGP, RIP, and IS-IS protocol modules.
"This 4.2 release adds support for the IETF's Martini draft standard to our ZebOS Advanced Routing Suite (ARS) family. Martini draft is one of the most widely used draft standard protocols on an MPLS network," said Nick Keating, President and CEO of IP Infusion. "Support of this feature will assist service providers and telecommunications customers in delivering VPN services. IP Infusion now has both Layer 2 and Layer 3 MPLS-VPN support, which provides the flexibility that our OEM customers need to deliver full support to their customers."
About Advanced Routing Suite Version 4.2 Features
The ZebOS Advanced Routing Suite (ARS) MPLS Layer 2 Virtual Circuit (VC) is an implementation of two IETF Martini drafts, l2circuit transport and l2circuit encapsulation. It encapsulates Ethernet frames from a local LAN, at the MPLS ingress, into an MPLS LSP tunnel and de-encapsulates at the PE egress. MPLS Layer 2 VC enables customers to extend their LAN across an MPLS WAN transparently.
The MPLS Layer2 VC is modular source code software to assist OEM customers to deliver their products in a timely manner to market. It is fully integrated into the ZebOS Network Services Module (NSM) and the ZebOS LDP protocol modules. It is written in ANSI C and has been ported to a variety of operating systems.
About IP Infusion's ZebOS Routing Suites
IP Infusion designs, develops, and markets its ZebOSTM family of advanced IP routing suites, which are based on a unique, modular, multi-process architecture featuring control-plane components that provide route redistribution and conversion, management services, and an OS/processor abstraction layer for routing and switching modules. This high-performance routing software features IPv4 and IPv6 versions of OSPF, BGP, and RIP routing protocols; MPLS, BGP-VPN, RSVP-TE, and CR-LDP switching and signaling protocols; and Mobile IP, routing redundancy, multicast, and virtual routing support. ZebOS software suites can be delivered as either portable, platform-independent source code, or in server solutions, which can be used to support proprietary systems and includes a number of OS dependant modules to quickly build on Linux, BSD, Solaris, VxWorks, OSE, and other popular operating systems. Processor support for Intel® Pentium, Motorola® PowerPCTM, Sun® SparcTM, and MIPS are provided.
ZebOS ARS Version 4.2 is available immediately for delivery. For further details, send an email to email@example.com, or call (408) 794.1500.
About IP Infusion (www.ipinfusion.com)
A leading provider of intelligent network software for enhanced IP services, IP Infusion is a developer of networking software that enables platforms, hardware, devices, and media across the Internet to communicate with each other openly and without dependence on specific technologies or platforms. Just as Unix and Windows are central to the PC and server markets, this leading edge software will drive the communication equipment market by providing the intelligence and manageability needed to develop equipment for creating enhanced IP services. IP Infusion was founded in 1999 and has more than 65 employees in its San Jose, California headquarters and elsewhere in the USA and Europe. The company has a growing global customer base in the wired and wireless networking markets and has alliances with the primary network processor (NPU) suppliers. IP Infusion is a member of the Network Processing Forum and an active participant in the IETF. For more information about the company and its products call 1-408-794-1500.
IP Infusion, the IP Infusion logo, and ZebOS are trademarks of IP Infusion Inc.
Previous Page | News by Category | News Search
If you found this page useful, bookmark and share it on: